Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYKaNDy Therapeutics Announces Positive Phase 2b Data in Post-Menopausal Women with its Lead Non-Hormonal Product NT-814PREV STORYEmergent BioSolutions Receives EMA Agreement for Proposed Development Path of Investigational Chikungunya VLP Vaccine Candidate